Search - tctmd.com

Displaying 921 - 940 of 1818

Sort: Relevancy | Date

Presentation NY Valves 2024

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Surgical Closure of the LAA: Patient Selection, Procedural Success, and Postprocedural Anticoagulation Strategies

Presenter: Guido Ascione

June 07, 2024

Presentation NY Valves 2024

Lessons Learned in TMVR Trial Design, Patient Selection, and Indications

Presenter: Chet Rihal

June 07, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

Presentation NY Valves 2024

PRO: The Left Atrial Appendage Is the Devil’s Playground – We Should Close Them All!

Presenter: Saibal Kar

June 07, 2024

Presentation NY Valves 2024

Atrial Fibrillation and Left Atrial Appendage Closure (Occlusion): The Gap Between Prevalence and Penetrance

Presenter: Vivek Y. Reddy

June 07, 2024

Presentation NY Valves 2024

When to Consider the Ross and Mitral Reconstruction?

Presenter: Ismail El-Hamamsy

June 07, 2024

Double Valve Reconstruction – Keys to Success

Presentation NY Valves 2024

Double Valve Surgery– Keys to Success

Presenter: Percy Boateng

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Mitral Valve Reconstruction in Connective Tissue Syndromes

Presenter: Ahmed El-Eshmawi

June 07, 2024

Presentation NY Valves 2024

Mitral Annular Calcification: A Management Challenge and Potential Strategies

Presenter: Mackram F. Eleid

June 07, 2024

Presentation NY Valves 2024

Understanding the Genetics and Classification of Connective Tissue Syndromes

Presenter: Amy Kontorovich

June 07, 2024

Presentation NY Valves 2024

Anatomy for Tricuspid Interventions: "Live" from the OR

Presenter: Isaac George

June 07, 2024

Presentation NY Valves 2024

What’s Next? Managing the Disease and Advanced Training

Presenter: Charles J. Davidson

June 07, 2024

Presentation NY Valves 2024

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Presenter: Georg Nickenig

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

The Compelling Case for Transcatheter Tricuspid Therapies

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Advertisement

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

Surgical Closure of the LAA: Patient Selection, Procedural Success, and Postprocedural Anticoagulation Strategies

Lessons Learned in TMVR Trial Design, Patient Selection, and Indications

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

PRO: The Left Atrial Appendage Is the Devil’s Playground – We Should Close Them All!

Atrial Fibrillation and Left Atrial Appendage Closure (Occlusion): The Gap Between Prevalence and Penetrance

When to Consider the Ross and Mitral Reconstruction?

Double Valve Surgery– Keys to Success

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Mitral Valve Reconstruction in Connective Tissue Syndromes

Mitral Annular Calcification: A Management Challenge and Potential Strategies

Understanding the Genetics and Classification of Connective Tissue Syndromes

Anatomy for Tricuspid Interventions: "Live" from the OR

What’s Next? Managing the Disease and Advanced Training

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

The Compelling Case for Transcatheter Tricuspid Therapies

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content